Scinai Immunotherapeutics (SCNI) Cash from Operations (QoQ) (2020 - 2025)
Scinai Immunotherapeutics (SCNI) Cash from Operations (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Scinai Immunotherapeutics | 3.74 Bn | 624.08 Mn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -47.36% |
| Mar 31, 2025 | 3.25% |
| Dec 31, 2024 | 47.20% |
| Sep 30, 2024 | -15.93% |
| Jun 30, 2024 | -20.16% |
| Mar 31, 2024 | -19.43% |
| Dec 31, 2023 | 44.87% |
| Sep 30, 2023 | 22.74% |
| Jun 30, 2023 | 5.98% |
| Mar 31, 2023 | -415.85% |
| Dec 31, 2022 | 68.82% |
| Sep 30, 2022 | 48.10% |
| Jun 30, 2022 | -231.67% |
| Mar 31, 2022 | 40.69% |
| Dec 31, 2021 | 69.89% |
| Sep 30, 2021 | 21.78% |
| Jun 30, 2021 | -581.90% |
| Mar 31, 2021 | 92.71% |
| Dec 31, 2020 | -54.26% |
| Sep 30, 2020 | 12.90% |